Cargando…
The Place of Sulfonylureas in Guidelines: Why Are There Differences?
This review describes a presentation at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and new insights” on Wednesday September 18, 2019 at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. It examines the current role...
Autor principal: | Amod, Aslam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261304/ https://www.ncbi.nlm.nih.gov/pubmed/32323155 http://dx.doi.org/10.1007/s13300-020-00811-3 |
Ejemplares similares
-
The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy
por: Yu, Miao
Publicado: (2020) -
Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
por: Mohan, Viswanathan, et al.
Publicado: (2022) -
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2015) -
Latest Evidence on Sulfonylureas: What’s New?
por: Leiter, Lawrence A.
Publicado: (2020) -
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)